Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Oncternal Announces First Patient Dosed in Cirmtuzumab, Paclitaxel Trial

americanpharmaceuticalreviewSeptember 13, 2018

Tag: Oncternal , Cirmtuzumab , Paclitaxel Trial

PharmaSources Customer Service